The 21% Correction: Why Public Markets Are No Longer Buying Biotech Platforms Without Clinical Anchors
The biotech markets of early 2026 have become a theater of the extreme, where the…
Author: admin
Stop Searching, Start Connecting: Your Global API & FDF Hub
If you’ve been in the pharma business for a while, you know that finding a…
Checkbook Darwinism: Why Merck and Roche Are Paying ‘Panic Premiums’ to Avert Extinction
The pharmaceutical sector has officially transitioned from cautious capital preservation to a state of aggressive,…
Regulatory Shock Trades: How FDA Letters Move Billions Before Lunch
CRL Regulatory Shock Trades: How FDA Letters Move Billions Before Lunch No fireworks. A 7:12…
Data Integrity’s New Price Tag: How Compliance Failures Now Move Stock Prices in Hours
At 9:15 a.m. Mumbai time, Nov. 6, 2015, a single document changed billions in market…
CRO Services Market Projected to Reach $175.5 Billion by 2032
The global contract research organization (CRO) services market is poised for significant growth, projected to…
Regulatory Pressure & Supply Shock: Why Europe’s Drug Shortages Became Chronic – and What Everyone’s Missing
“Shortages aren’t accidents; they’re features of how the market is built.” Outside declared emergencies EMA…
Nitrosamines 2.0: new AI thresholds, new “casualties,” and finally predictable rules
The story really does begin in a hot stretch of 2025, when three regulators –…
Ori Biotech Secures FDA Advanced Manufacturing Designation for IRO Platform
Ori Biotech has achieved a significant milestone by securing the FDA’s Advanced Manufacturing Technology designation…
Cracking Down on Orphan Drug Abuse: The ORPHAN Cures Act and Its Impact
Orphan Drug Profits vs. Patients: The Orphan Drug Act of 1983 was meant to encourage…